nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS1—kidney cancer	0.422	0.636	CbGaD
Aminosalicylic Acid—PTGS2—kidney cancer	0.241	0.364	CbGaD
Aminosalicylic Acid—Diflunisal—PTGS1—kidney cancer	0.000916	0.253	CrCbGaD
Aminosalicylic Acid—Mesalazine—PTGS1—kidney cancer	0.000718	0.199	CrCbGaD
Aminosalicylic Acid—Diflunisal—PTGS2—kidney cancer	0.000523	0.145	CrCbGaD
Aminosalicylic Acid—Salicylic acid—PTGS1—kidney cancer	0.000509	0.141	CrCbGaD
Aminosalicylic Acid—Anaemia—Sorafenib—kidney cancer	0.000456	0.00261	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vinblastine—kidney cancer	0.000456	0.00261	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Vincristine—kidney cancer	0.000456	0.00261	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Everolimus—kidney cancer	0.000455	0.0026	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Gemcitabine—kidney cancer	0.000455	0.0026	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Everolimus—kidney cancer	0.000454	0.0026	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Vincristine—kidney cancer	0.000452	0.00259	CcSEcCtD
Aminosalicylic Acid—Purpura—Capecitabine—kidney cancer	0.000451	0.00258	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Everolimus—kidney cancer	0.000451	0.00258	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vinblastine—kidney cancer	0.000444	0.00254	CcSEcCtD
Aminosalicylic Acid—Anorexia—Everolimus—kidney cancer	0.000442	0.00253	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Sorafenib—kidney cancer	0.000442	0.00253	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Erlotinib—kidney cancer	0.000439	0.00251	CcSEcCtD
Aminosalicylic Acid—Anaemia—Sunitinib—kidney cancer	0.000439	0.00251	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Erlotinib—kidney cancer	0.000438	0.00251	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Erlotinib—kidney cancer	0.000435	0.00249	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000435	0.00249	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Gemcitabine—kidney cancer	0.000432	0.00247	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Gemcitabine—kidney cancer	0.000429	0.00246	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Temsirolimus—kidney cancer	0.000427	0.00244	CcSEcCtD
Aminosalicylic Acid—Anorexia—Erlotinib—kidney cancer	0.000427	0.00244	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Sunitinib—kidney cancer	0.000425	0.00243	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000417	0.00239	CcSEcCtD
Aminosalicylic Acid—Anaemia—Dactinomycin—kidney cancer	0.000415	0.00238	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Paclitaxel—kidney cancer	0.000414	0.00237	CcSEcCtD
Aminosalicylic Acid—Dizziness—Temsirolimus—kidney cancer	0.000412	0.00236	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—kidney cancer	0.000411	0.114	CrCbGaD
Aminosalicylic Acid—Decreased appetite—Vinblastine—kidney cancer	0.000405	0.00232	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Everolimus—kidney cancer	0.000403	0.00231	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Dactinomycin—kidney cancer	0.000402	0.0023	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Pazopanib—kidney cancer	0.000402	0.0023	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000401	0.0023	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Everolimus—kidney cancer	0.000401	0.00229	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Paclitaxel—kidney cancer	0.0004	0.00229	CcSEcCtD
Aminosalicylic Acid—Vomiting—Temsirolimus—kidney cancer	0.000397	0.00227	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Sorafenib—kidney cancer	0.000395	0.00226	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Sorafenib—kidney cancer	0.000394	0.00226	CcSEcCtD
Aminosalicylic Acid—Rash—Temsirolimus—kidney cancer	0.000393	0.00225	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Temsirolimus—kidney cancer	0.000393	0.00225	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Sorafenib—kidney cancer	0.000391	0.00224	CcSEcCtD
Aminosalicylic Acid—Headache—Temsirolimus—kidney cancer	0.000391	0.00224	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Erlotinib—kidney cancer	0.000389	0.00223	CcSEcCtD
Aminosalicylic Acid—Dizziness—Pazopanib—kidney cancer	0.000389	0.00222	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000386	0.00221	CcSEcCtD
Aminosalicylic Acid—Anorexia—Sorafenib—kidney cancer	0.000384	0.0022	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vinblastine—kidney cancer	0.000381	0.00218	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Sunitinib—kidney cancer	0.00038	0.00218	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Sunitinib—kidney cancer	0.000379	0.00217	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Everolimus—kidney cancer	0.000379	0.00217	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Capecitabine—kidney cancer	0.000378	0.00217	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Sunitinib—kidney cancer	0.000376	0.00216	CcSEcCtD
Aminosalicylic Acid—Vomiting—Pazopanib—kidney cancer	0.000374	0.00214	CcSEcCtD
Aminosalicylic Acid—Anaemia—Vincristine—kidney cancer	0.000371	0.00213	CcSEcCtD
Aminosalicylic Acid—Rash—Pazopanib—kidney cancer	0.00037	0.00212	CcSEcCtD
Aminosalicylic Acid—Nausea—Temsirolimus—kidney cancer	0.00037	0.00212	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Pazopanib—kidney cancer	0.00037	0.00212	CcSEcCtD
Aminosalicylic Acid—Anorexia—Sunitinib—kidney cancer	0.000369	0.00211	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vinblastine—kidney cancer	0.000368	0.00211	CcSEcCtD
Aminosalicylic Acid—Headache—Pazopanib—kidney cancer	0.000368	0.00211	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Everolimus—kidney cancer	0.000367	0.0021	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Everolimus—kidney cancer	0.000367	0.0021	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Erlotinib—kidney cancer	0.000366	0.0021	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Paclitaxel—kidney cancer	0.000362	0.00207	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Vincristine—kidney cancer	0.000359	0.00206	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Paclitaxel—kidney cancer	0.000359	0.00206	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dactinomycin—kidney cancer	0.000359	0.00206	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Erlotinib—kidney cancer	0.000354	0.00203	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Erlotinib—kidney cancer	0.000354	0.00203	CcSEcCtD
Aminosalicylic Acid—Anaemia—Gemcitabine—kidney cancer	0.000352	0.00202	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Sorafenib—kidney cancer	0.00035	0.002	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dactinomycin—kidney cancer	0.00035	0.002	CcSEcCtD
Aminosalicylic Acid—Nausea—Pazopanib—kidney cancer	0.000349	0.002	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000348	0.00199	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vinblastine—kidney cancer	0.000343	0.00196	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Everolimus—kidney cancer	0.000342	0.00196	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Gemcitabine—kidney cancer	0.000341	0.00195	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Capecitabine—kidney cancer	0.00034	0.00195	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Sunitinib—kidney cancer	0.000337	0.00193	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000335	0.00192	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Sorafenib—kidney cancer	0.000329	0.00189	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Capecitabine—kidney cancer	0.000328	0.00188	CcSEcCtD
Aminosalicylic Acid—Jaundice—Capecitabine—kidney cancer	0.000327	0.00187	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000322	0.00184	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Vincristine—kidney cancer	0.000321	0.00184	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vincristine—kidney cancer	0.000321	0.00184	CcSEcCtD
Aminosalicylic Acid—Urticaria—Sorafenib—kidney cancer	0.00032	0.00183	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Paclitaxel—kidney cancer	0.000319	0.00183	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dactinomycin—kidney cancer	0.000319	0.00183	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vinblastine—kidney cancer	0.000319	0.00182	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Sorafenib—kidney cancer	0.000318	0.00182	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Sorafenib—kidney cancer	0.000318	0.00182	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Everolimus—kidney cancer	0.000317	0.00182	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Sunitinib—kidney cancer	0.000317	0.00181	CcSEcCtD
Aminosalicylic Acid—Flatulence—Paclitaxel—kidney cancer	0.000314	0.0018	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—kidney cancer	0.000313	0.00179	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Capecitabine—kidney cancer	0.000313	0.00179	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vincristine—kidney cancer	0.000312	0.00179	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Paclitaxel—kidney cancer	0.000312	0.00179	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vinblastine—kidney cancer	0.000308	0.00176	CcSEcCtD
Aminosalicylic Acid—Dizziness—Everolimus—kidney cancer	0.000307	0.00176	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Sunitinib—kidney cancer	0.000306	0.00175	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Sunitinib—kidney cancer	0.000306	0.00175	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Erlotinib—kidney cancer	0.000306	0.00175	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Gemcitabine—kidney cancer	0.000305	0.00175	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Gemcitabine—kidney cancer	0.000304	0.00174	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Gemcitabine—kidney cancer	0.000302	0.00173	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Capecitabine—kidney cancer	0.000301	0.00172	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dactinomycin—kidney cancer	0.0003	0.00172	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Capecitabine—kidney cancer	0.000297	0.0017	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000297	0.0017	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Sorafenib—kidney cancer	0.000297	0.0017	CcSEcCtD
Aminosalicylic Acid—Anorexia—Gemcitabine—kidney cancer	0.000296	0.0017	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vinblastine—kidney cancer	0.000296	0.0017	CcSEcCtD
Aminosalicylic Acid—Dizziness—Erlotinib—kidney cancer	0.000296	0.00169	CcSEcCtD
Aminosalicylic Acid—Vomiting—Everolimus—kidney cancer	0.000295	0.00169	CcSEcCtD
Aminosalicylic Acid—Anaemia—Paclitaxel—kidney cancer	0.000295	0.00169	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Capecitabine—kidney cancer	0.000295	0.00169	CcSEcCtD
Aminosalicylic Acid—Rash—Everolimus—kidney cancer	0.000293	0.00167	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Everolimus—kidney cancer	0.000292	0.00167	CcSEcCtD
Aminosalicylic Acid—Headache—Vinblastine—kidney cancer	0.000292	0.00167	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—kidney cancer	0.000291	0.0805	CrCbGaD
Aminosalicylic Acid—Purpura—Doxorubicin—kidney cancer	0.000291	0.00166	CcSEcCtD
Aminosalicylic Acid—Headache—Everolimus—kidney cancer	0.000291	0.00166	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dactinomycin—kidney cancer	0.00029	0.00166	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dactinomycin—kidney cancer	0.00029	0.00166	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—kidney cancer	0.000287	0.00164	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Paclitaxel—kidney cancer	0.000286	0.00163	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Sunitinib—kidney cancer	0.000286	0.00163	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vincristine—kidney cancer	0.000285	0.00163	CcSEcCtD
Aminosalicylic Acid—Vomiting—Erlotinib—kidney cancer	0.000285	0.00163	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Vincristine—kidney cancer	0.000283	0.00162	CcSEcCtD
Aminosalicylic Acid—Rash—Erlotinib—kidney cancer	0.000282	0.00162	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Erlotinib—kidney cancer	0.000282	0.00161	CcSEcCtD
Aminosalicylic Acid—Headache—Erlotinib—kidney cancer	0.00028	0.00161	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00028	0.0016	CcSEcCtD
Aminosalicylic Acid—Nausea—Vinblastine—kidney cancer	0.000277	0.00158	CcSEcCtD
Aminosalicylic Acid—Nausea—Everolimus—kidney cancer	0.000276	0.00158	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Sorafenib—kidney cancer	0.000276	0.00158	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Gemcitabine—kidney cancer	0.00027	0.00155	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dactinomycin—kidney cancer	0.00027	0.00155	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00027	0.00154	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000268	0.00154	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vincristine—kidney cancer	0.000268	0.00153	CcSEcCtD
Aminosalicylic Acid—Dizziness—Sorafenib—kidney cancer	0.000266	0.00152	CcSEcCtD
Aminosalicylic Acid—Nausea—Erlotinib—kidney cancer	0.000266	0.00152	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Sunitinib—kidney cancer	0.000265	0.00152	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Capecitabine—kidney cancer	0.000262	0.0015	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vincristine—kidney cancer	0.000259	0.00148	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vincristine—kidney cancer	0.000259	0.00148	CcSEcCtD
Aminosalicylic Acid—Flatulence—Capecitabine—kidney cancer	0.000258	0.00148	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Capecitabine—kidney cancer	0.000256	0.00147	CcSEcCtD
Aminosalicylic Acid—Dizziness—Sunitinib—kidney cancer	0.000256	0.00147	CcSEcCtD
Aminosalicylic Acid—Vomiting—Sorafenib—kidney cancer	0.000256	0.00147	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Paclitaxel—kidney cancer	0.000255	0.00146	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Paclitaxel—kidney cancer	0.000255	0.00146	CcSEcCtD
Aminosalicylic Acid—Rash—Sorafenib—kidney cancer	0.000254	0.00145	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Sorafenib—kidney cancer	0.000254	0.00145	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Paclitaxel—kidney cancer	0.000253	0.00145	CcSEcCtD
Aminosalicylic Acid—Headache—Sorafenib—kidney cancer	0.000252	0.00144	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dactinomycin—kidney cancer	0.000251	0.00144	CcSEcCtD
Aminosalicylic Acid—Anorexia—Paclitaxel—kidney cancer	0.000248	0.00142	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ABCB1—kidney cancer	0.000248	0.0685	CrCbGaD
Aminosalicylic Acid—Vomiting—Sunitinib—kidney cancer	0.000246	0.00141	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Gemcitabine—kidney cancer	0.000246	0.00141	CcSEcCtD
Aminosalicylic Acid—Rash—Sunitinib—kidney cancer	0.000244	0.0014	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Sunitinib—kidney cancer	0.000244	0.0014	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—kidney cancer	0.000244	0.0014	CcSEcCtD
Aminosalicylic Acid—Headache—Sunitinib—kidney cancer	0.000243	0.00139	CcSEcCtD
Aminosalicylic Acid—Anaemia—Capecitabine—kidney cancer	0.000242	0.00139	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vincristine—kidney cancer	0.000241	0.00138	CcSEcCtD
Aminosalicylic Acid—Nausea—Sorafenib—kidney cancer	0.000239	0.00137	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Capecitabine—kidney cancer	0.000234	0.00134	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dactinomycin—kidney cancer	0.000233	0.00134	CcSEcCtD
Aminosalicylic Acid—Rash—Dactinomycin—kidney cancer	0.000231	0.00132	CcSEcCtD
Aminosalicylic Acid—Nausea—Sunitinib—kidney cancer	0.00023	0.00132	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Paclitaxel—kidney cancer	0.000226	0.0013	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000225	0.00129	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vincristine—kidney cancer	0.000224	0.00128	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000221	0.00127	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—kidney cancer	0.000219	0.00125	CcSEcCtD
Aminosalicylic Acid—Nausea—Dactinomycin—kidney cancer	0.000218	0.00125	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vincristine—kidney cancer	0.000217	0.00124	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000213	0.00122	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Gemcitabine—kidney cancer	0.000213	0.00122	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000212	0.00121	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—kidney cancer	0.00021	0.0012	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Capecitabine—kidney cancer	0.00021	0.0012	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Capecitabine—kidney cancer	0.000209	0.0012	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vincristine—kidney cancer	0.000208	0.00119	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Capecitabine—kidney cancer	0.000208	0.00119	CcSEcCtD
Aminosalicylic Acid—Urticaria—Paclitaxel—kidney cancer	0.000207	0.00118	CcSEcCtD
Aminosalicylic Acid—Rash—Vincristine—kidney cancer	0.000207	0.00118	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vincristine—kidney cancer	0.000206	0.00118	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Paclitaxel—kidney cancer	0.000206	0.00118	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Paclitaxel—kidney cancer	0.000206	0.00118	CcSEcCtD
Aminosalicylic Acid—Headache—Vincristine—kidney cancer	0.000205	0.00118	CcSEcCtD
Aminosalicylic Acid—Anorexia—Capecitabine—kidney cancer	0.000204	0.00117	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—kidney cancer	0.000202	0.00115	CcSEcCtD
Aminosalicylic Acid—Vomiting—Gemcitabine—kidney cancer	0.000198	0.00113	CcSEcCtD
Aminosalicylic Acid—Rash—Gemcitabine—kidney cancer	0.000196	0.00112	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Gemcitabine—kidney cancer	0.000196	0.00112	CcSEcCtD
Aminosalicylic Acid—Headache—Gemcitabine—kidney cancer	0.000195	0.00112	CcSEcCtD
Aminosalicylic Acid—Nausea—Vincristine—kidney cancer	0.000195	0.00111	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—kidney cancer	0.000194	0.00111	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Paclitaxel—kidney cancer	0.000192	0.0011	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—kidney cancer	0.000191	0.0011	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—kidney cancer	0.00019	0.00109	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Capecitabine—kidney cancer	0.000186	0.00106	CcSEcCtD
Aminosalicylic Acid—Nausea—Gemcitabine—kidney cancer	0.000185	0.00106	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000184	0.00106	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Paclitaxel—kidney cancer	0.000178	0.00102	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.000175	0.001	CcSEcCtD
Aminosalicylic Acid—Dizziness—Paclitaxel—kidney cancer	0.000172	0.000986	CcSEcCtD
Aminosalicylic Acid—Urticaria—Capecitabine—kidney cancer	0.00017	0.000972	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Capecitabine—kidney cancer	0.000169	0.000967	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Capecitabine—kidney cancer	0.000169	0.000967	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—kidney cancer	0.000169	0.000966	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—kidney cancer	0.000166	0.000952	CcSEcCtD
Aminosalicylic Acid—Vomiting—Paclitaxel—kidney cancer	0.000166	0.000948	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—kidney cancer	0.000165	0.000946	CcSEcCtD
Aminosalicylic Acid—Rash—Paclitaxel—kidney cancer	0.000164	0.00094	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Paclitaxel—kidney cancer	0.000164	0.000939	CcSEcCtD
Aminosalicylic Acid—Headache—Paclitaxel—kidney cancer	0.000163	0.000934	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Capecitabine—kidney cancer	0.000157	0.000901	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—kidney cancer	0.000156	0.000893	CcSEcCtD
Aminosalicylic Acid—Nausea—Paclitaxel—kidney cancer	0.000155	0.000885	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—kidney cancer	0.000151	0.000865	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Capecitabine—kidney cancer	0.000146	0.000837	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000143	0.000817	CcSEcCtD
Aminosalicylic Acid—Dizziness—Capecitabine—kidney cancer	0.000141	0.000809	CcSEcCtD
Aminosalicylic Acid—Vomiting—Capecitabine—kidney cancer	0.000136	0.000778	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—kidney cancer	0.000135	0.000773	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—kidney cancer	0.000135	0.000772	CcSEcCtD
Aminosalicylic Acid—Rash—Capecitabine—kidney cancer	0.000135	0.000771	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Capecitabine—kidney cancer	0.000135	0.00077	CcSEcCtD
Aminosalicylic Acid—Headache—Capecitabine—kidney cancer	0.000134	0.000766	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—kidney cancer	0.000134	0.000766	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—kidney cancer	0.000131	0.000752	CcSEcCtD
Aminosalicylic Acid—Nausea—Capecitabine—kidney cancer	0.000127	0.000727	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—kidney cancer	0.00012	0.000685	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000119	0.000681	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000113	0.000645	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—kidney cancer	0.000109	0.000626	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—kidney cancer	0.000109	0.000623	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—kidney cancer	0.000109	0.000623	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—kidney cancer	0.000101	0.000581	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—kidney cancer	9.42e-05	0.000539	CcSEcCtD
Aminosalicylic Acid—Dizziness—Doxorubicin—kidney cancer	9.11e-05	0.000521	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—kidney cancer	8.76e-05	0.000501	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—kidney cancer	8.68e-05	0.000497	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—kidney cancer	8.68e-05	0.000497	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—kidney cancer	8.63e-05	0.000494	CcSEcCtD
Aminosalicylic Acid—Nausea—Doxorubicin—kidney cancer	8.18e-05	0.000468	CcSEcCtD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.07e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PIK3CA—kidney cancer	4.06e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.05e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PIK3CA—kidney cancer	4.03e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PIK3CA—kidney cancer	4.01e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ST3GAL2—kidney cancer	4e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTSB—kidney cancer	3.99e-05	0.000252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTSD—kidney cancer	3.97e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTEN—kidney cancer	3.96e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.96e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC5A3—kidney cancer	3.95e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PGK1—kidney cancer	3.95e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—kidney cancer	3.95e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.93e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LDHB—kidney cancer	3.88e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTP1—kidney cancer	3.87e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.87e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TSC2—kidney cancer	3.86e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PSMD7—kidney cancer	3.86e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.86e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APRT—kidney cancer	3.85e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FH—kidney cancer	3.85e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.84e-05	0.000242	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.8e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PIK3CA—kidney cancer	3.79e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.76e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC5A3—kidney cancer	3.75e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PGK1—kidney cancer	3.75e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.73e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—TSC2—kidney cancer	3.71e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LDHB—kidney cancer	3.67e-05	0.000232	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SFRP2—kidney cancer	3.67e-05	0.000232	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ABCB1—kidney cancer	3.67e-05	0.000232	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—kidney cancer	3.63e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPC3—kidney cancer	3.62e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PSMD7—kidney cancer	3.56e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTM1—kidney cancer	3.56e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA2—kidney cancer	3.52e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.52e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKAP13—kidney cancer	3.5e-05	0.000221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP2—kidney cancer	3.5e-05	0.000221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PAK1—kidney cancer	3.46e-05	0.000219	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—MAPK3—kidney cancer	3.44e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALAD—kidney cancer	3.43e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCEB2—kidney cancer	3.43e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCEB1—kidney cancer	3.43e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KIT—kidney cancer	3.41e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK3—kidney cancer	3.38e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA1—kidney cancer	3.38e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP1A1—kidney cancer	3.37e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CA9—kidney cancer	3.36e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.36e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.35e-05	0.000211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.35e-05	0.000211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.32e-05	0.00021	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.28e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KIT—kidney cancer	3.27e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—MAPK1—kidney cancer	3.27e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.27e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.25e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGR1—kidney cancer	3.24e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.24e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC2A1—kidney cancer	3.22e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK1—kidney cancer	3.22e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRB7—kidney cancer	3.2e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—JUNB—kidney cancer	3.2e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PIK3CA—kidney cancer	3.15e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA2—kidney cancer	3.15e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PGK1—kidney cancer	3.14e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC5A3—kidney cancer	3.14e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—kidney cancer	3.09e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LDHB—kidney cancer	3.08e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—kidney cancer	3.04e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDH1—kidney cancer	3.01e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ITPR2—kidney cancer	2.98e-05	0.000188	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.92e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CRABP1—kidney cancer	2.86e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PIK3CA—kidney cancer	2.84e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PIK3CA—kidney cancer	2.79e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL14—kidney cancer	2.78e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.77e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.77e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNA1—kidney cancer	2.7e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.69e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HSPB1—kidney cancer	2.68e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EIF4EBP1—kidney cancer	2.68e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RAF1—kidney cancer	2.68e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA9—kidney cancer	2.67e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RELA—kidney cancer	2.66e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ITPR2—kidney cancer	2.66e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB2—kidney cancer	2.65e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—kidney cancer	2.64e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.63e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MTOR—kidney cancer	2.61e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—kidney cancer	2.61e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.61e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN2B—kidney cancer	2.6e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RAF1—kidney cancer	2.57e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RELA—kidney cancer	2.56e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB2—kidney cancer	2.54e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ITPR2—kidney cancer	2.52e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—POMC—kidney cancer	2.52e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—MTOR—kidney cancer	2.51e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—kidney cancer	2.5e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ANXA1—kidney cancer	2.49e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC1—kidney cancer	2.49e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PSMD7—kidney cancer	2.49e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.49e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1B—kidney cancer	2.45e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.45e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTT1—kidney cancer	2.42e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ACHE—kidney cancer	2.42e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FLT1—kidney cancer	2.42e-05	0.000153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1B—kidney cancer	2.35e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—JUN—kidney cancer	2.33e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—kidney cancer	2.32e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SCARB1—kidney cancer	2.29e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.28e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CRABP1—kidney cancer	2.27e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—kidney cancer	2.26e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TSC2—kidney cancer	2.25e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUNB—kidney cancer	2.24e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PAK1—kidney cancer	2.24e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PSMD7—kidney cancer	2.23e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.21e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—kidney cancer	2.17e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—kidney cancer	2.11e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSMD7—kidney cancer	2.11e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ITPR2—kidney cancer	2.11e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC5A5—kidney cancer	2.08e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIF1A—kidney cancer	2.08e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TSC2—kidney cancer	2.08e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A1—kidney cancer	2.01e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—kidney cancer	2.01e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KIT—kidney cancer	1.99e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.95e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.94e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK3—kidney cancer	1.93e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ACHE—kidney cancer	1.92e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTT1—kidney cancer	1.92e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A1—kidney cancer	1.91e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JUNB—kidney cancer	1.89e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK1—kidney cancer	1.84e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APC—kidney cancer	1.83e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KIT—kidney cancer	1.83e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—kidney cancer	1.83e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDH1—kidney cancer	1.83e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—kidney cancer	1.82e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SCARB1—kidney cancer	1.82e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTGS1—kidney cancer	1.8e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—kidney cancer	1.77e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PSMD7—kidney cancer	1.77e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—kidney cancer	1.75e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—kidney cancer	1.73e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—BRAF—kidney cancer	1.72e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.7e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—kidney cancer	1.68e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—kidney cancer	1.68e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—kidney cancer	1.66e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC5A5—kidney cancer	1.65e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A1—kidney cancer	1.6e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—kidney cancer	1.59e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—kidney cancer	1.59e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAF1—kidney cancer	1.56e-05	9.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RELA—kidney cancer	1.55e-05	9.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—kidney cancer	1.54e-05	9.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—kidney cancer	1.54e-05	9.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—kidney cancer	1.54e-05	9.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—kidney cancer	1.53e-05	9.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MTOR—kidney cancer	1.52e-05	9.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—kidney cancer	1.52e-05	9.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1A1—kidney cancer	1.46e-05	9.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—kidney cancer	1.46e-05	9.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC2—kidney cancer	1.45e-05	9.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RAF1—kidney cancer	1.44e-05	9.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—kidney cancer	1.43e-05	9.02e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—kidney cancer	1.42e-05	8.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTOR—kidney cancer	1.4e-05	8.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—kidney cancer	1.4e-05	8.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—kidney cancer	1.4e-05	8.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KDR—kidney cancer	1.39e-05	8.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—kidney cancer	1.39e-05	8.79e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JUN—kidney cancer	1.36e-05	8.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.35e-05	8.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—kidney cancer	1.35e-05	8.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—kidney cancer	1.33e-05	8.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—kidney cancer	1.32e-05	8.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—kidney cancer	1.31e-05	8.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KIT—kidney cancer	1.28e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—kidney cancer	1.28e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—kidney cancer	1.26e-05	7.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—kidney cancer	1.25e-05	7.87e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—kidney cancer	1.23e-05	7.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—kidney cancer	1.23e-05	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TSC2—kidney cancer	1.23e-05	7.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—kidney cancer	1.22e-05	7.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—kidney cancer	1.22e-05	7.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—kidney cancer	1.21e-05	7.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BRAF—kidney cancer	1.21e-05	7.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.2e-05	7.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1A1—kidney cancer	1.16e-05	7.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK3—kidney cancer	1.12e-05	7.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—kidney cancer	1.09e-05	6.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KIT—kidney cancer	1.09e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—kidney cancer	1.09e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK1—kidney cancer	1.07e-05	6.75e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK3—kidney cancer	1.04e-05	6.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BRAF—kidney cancer	1.02e-05	6.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—kidney cancer	1.01e-05	6.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—kidney cancer	1.01e-05	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAF1—kidney cancer	1.01e-05	6.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RELA—kidney cancer	1e-05	6.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—kidney cancer	9.97e-06	6.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK1—kidney cancer	9.87e-06	6.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTOR—kidney cancer	9.84e-06	6.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.54e-06	6.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—kidney cancer	9.32e-06	5.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—kidney cancer	9.28e-06	5.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—kidney cancer	9.23e-06	5.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—kidney cancer	9.03e-06	5.71e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCND1—kidney cancer	8.81e-06	5.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUN—kidney cancer	8.79e-06	5.55e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—kidney cancer	8.72e-06	5.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—kidney cancer	8.7e-06	5.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—kidney cancer	8.66e-06	5.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—kidney cancer	8.56e-06	5.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RAF1—kidney cancer	8.52e-06	5.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—kidney cancer	8.5e-06	5.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—kidney cancer	8.43e-06	5.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTOR—kidney cancer	8.32e-06	5.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—kidney cancer	8.31e-06	5.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—kidney cancer	7.81e-06	4.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—kidney cancer	7.68e-06	4.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—kidney cancer	7.59e-06	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—kidney cancer	7.38e-06	4.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK3—kidney cancer	7.26e-06	4.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—kidney cancer	7.19e-06	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—kidney cancer	7.06e-06	4.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK1—kidney cancer	6.91e-06	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—kidney cancer	6.53e-06	4.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK3—kidney cancer	6.14e-06	3.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—kidney cancer	6.02e-06	3.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—kidney cancer	6e-06	3.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—kidney cancer	5.98e-06	3.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK1—kidney cancer	5.85e-06	3.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—kidney cancer	5.8e-06	3.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—kidney cancer	5.52e-06	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—kidney cancer	5.35e-06	3.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—kidney cancer	5.07e-06	3.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—kidney cancer	4.25e-06	2.68e-05	CbGpPWpGaD
